This report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.Industry Research on Global Immunology Market 2018-2022 of 117 pages is now available with reportsnreports.com under Pharmaceuticals section of its market research library. The analysts forecast global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.
Download pdf at www.reportsnreports.com/contacts/r…aspx?name=1286845 .
The latest trend gaining momentum in the Immunology market is significant pipeline.
There are multiple promising immunological agents in the pipeline, which boost the market growth after their approval. The approval of new therapeutic agents broadens the options available for the treatment and thus leads to the increase in demand for the therapeutic regimen.
There are approximately 51 molecules under different clinical trial stages globally.
Complete report available at www.reportsnreports.com/contacts/.aspx?name=1286845 .
Key players in the global immunology market: AbbVie, Amgen, F. Hoffmann-La Roche, and Johnson & Johnson.
Other Prominent Vendors in the market are: Angimmune, Bionor Pharma, Boston Biomedical, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics, Forty Seven, HANSOH, Immatics Biatechnologies, lmmunovaccine, Karyopharm Therapeutics, MabVax Therapeutics, MedImmune, MOLOGEN, Neon Therapeutics, NewLink Genetics, Novartis, ONCOQUEST, and Oncotherapeutics.
Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential.
Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers
According to the report, one of the major drivers for immunology market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally.
When the body’s immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators.
Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US.
With the rising incidences of infectious diseases, the demand for immunology products will increase in the coming years.
Table of Contents
PART 01: Executive Summary
PART 02: Scope of The Report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market Landscape
Market Segmentation Analysis
PART 06: Market Sizing
Market Sizing 2017
Market Size and Forecast
PART 07: Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Threat of New Entrants
Threat of Substitutes
Threat of Rivalry
PART 08: Pipeline Landscape
PART 09: Market Segmentation by Category
Segmentation by Category
Comparison by Category
Global Immunosuppressants Market
Global Immuno Boosters Market
Market Opportunity by Category
PART 10: Market Segmentation by Indication
PART 11: Customer Landscape
PART 12: Regional Landscape
Immunology Market in Americas
Immunology Market in Emea
Immunology Market in Apac
PART 13: Decision Framework
PART 14: Drivers and Challenges
PART 15: Market Trends
Collaborations and Partnerships For R&D
Advanced Diagnostic Technologies
PART 16: Vendor Landscape
PART 17: Vendor Analysis
Market Positioning of Vendors
F. Hoffmann-La Roche
Johnson & Johnson
PART 18: Appendix
List of Abbreviations